Xie, Linjun
Ding, Leyun
Tang, Lian
Yang, Zuming
Wu, Dan
Wang, Wenjuan
Mao, Juehui
Shi, Lu
Liu, Chun
Duan, Lufen
Xu, Jinhui
Zhou, Qin
Sun, Jiantong
Ding, Xinyuan
Funding for this research was provided by:
Jiangsu Pharmaceutical Association (H202052, H202024 and H202011, H202052, H202024 and H202011, H202052, H202024 and H202011)
Wu Jieping Medical Foundation (320.6750.2020-4-37 and 320.6750.2020-12-69, 320.6750.2020-4-37 and 320.6750.2020-12-69)
Science and Technology Funds of Suzhou Municipality (SYSD2020188)
Article History
Received: 9 November 2022
Accepted: 31 May 2023
First Online: 19 July 2023
Declarations
:
: This study was submitted to the Ethics Committee of the Affiliated Suzhou Hospital of Nanjing Medical University and ethical approval No. (L20129901). All methods were carried out in accordance with relevant guidelines and regulations. All participants signed informed consent form about voluntary participation in the study. For all participants who under 16 years of age, we obtained informed consent from their parents or legal guardians.
: Not applicable.
: The authors declared that they have no competing interests.